-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

508. Bone Marrow Failure: Acquired: Poster II

Symposia: Bone Marrow Failure: Acquired Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Jenna A. Fernandez, PhD1, Yael Kusne, MD, PhD2, Fernanda Gutierrez-Rodrigues, PhD3, Bhavisha A. Patel, MD3, Christy Finke, BS1*, Emma M. Groarke, MD3, Matthew J Koster, M.D.4*, Abhishek A. Mangaonkar, MBBS5, Naseema Gangat, MBBS1, Kenneth Warrington6*, Kaaren K. Reichard, MD7, Horatiu Olteanu, M.D., Ph.D.8, David Viswanatha, MD9, Rong He, MD10, Megan Sullivan, M.D.11*, Kambiz Kalantari, M.D.12*, Alexander Hines, M.D.13*, Daniel Montes, M.D.6*, Neal S. Young, MD3, David B Beck, MD, PhD14,15*, Wazim Ismail Mohammed, Ph.D.16*, Alexandre Gaspar-Maia, PhD5*, Terra L. Lasho, PhD1 and Mrinal M. Patnaik, MD, MBBS17

1Division of Hematology, Mayo Clinic, Rochester, MN
2Mayo Clinic, Phoenix, AZ
3Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
4Division of Rheumatology, Mayo Clinic, Rochester, MN
5Mayo Clinic, Rochester, MN
6Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
7Department of Pathology, Mayo Clinic, Rochester, MN
8Division of Hematopathology, Mayo Clinic, Rochester, MN
9Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester
10Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
11Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Phoenix, AZ
12Division of Nephrology & Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN
13Division of Dermatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
14Division of Rheumatology, Department of Medicine, NYU Grossman School of Medicine, New York
15Center for Human Genetics and Genomics, NYU Grossman School of Medicine, New York, NY
16Experimental Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN
17Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Alexander Röth, MD1, Guangsheng He2*, Andres Brodsky3*, Chatree Chai-Adisaksopha, M.D., Ph.D.4*, Narcisa Sonia Comia5*, Anna Gaya6*, Martin Höglund, MD, PhD7, Richard J. Kelly, MBChB, PhD8*, Ahlam Naila Kori, MD9*, Je-Hwan Lee10*, Naoshi Obara, MD, PhD11*, Antonio M Risitano, MD, PhD12, Anita Appius, PhD13*, Leigh Beveridge14*, Brittany Gentile, PhD14*, Zilu Zhang15*, Bing Han16* and Sasha Sreckovic, MD17*

1Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany
2Jiangsu Province Hospital, Nanjing, China
3Hematology Division, Hospital de Clinicas “José de San Martín”, University of Buenos Aires, and Organizacion Medica de Investigacion (OMI), Buenos Aires, Argentina
4Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
5Research Center, Mary Mediatrix Medical Center, Lipa, Philippines
6Hematology Department, Hospital Clinic Barcelona, Barcelona, Spain
7Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
8Department of Haematology, St. James’s University Hospital, Leeds, United Kingdom
9Department of Haematology, Hospital Tengku Ampuan Afzan, Kuantan, Malaysia
10Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
11Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan
12Hematology and BMT Unit, AORN San Giuseppe Moscati, Avellino, Italy
13F. Hoffmann-La Roche Ltd, Basel, Switzerland
14Genentech, Inc., South San Francisco, CA
15Roche Product Development, Shanghai, China
16Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Peking, China
17Genentech, Inc, South San Francisco

Fengkui Zhang1*, Bing Han2*, Li Zhang3* and Xin Zhao4

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology Blood Diseases Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Tianjin, China
2Department of Hematology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology&Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
4State Key Laboratory of Experimental Hematology,National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Ken Ishiyama, MD, PhD1,2, Ritsuro Suzuki, MD, PhD3, Kinuko Mitani, MD, PhD4*, Hiroyuki Maruyama, MD, PhD5*, Yasushi Onishi, MD, PhD6*, Kensuke Usuki, MD, PhD7, Hideo Koh, MD, PhD8,9*, Katsuto Takenaka, MD, PhD10, Seishi Ogawa, MD, PhD11, Kana Matsumoto, PhD12*, Takuto Takahashi, MD, PhD13*, Kazuyoshi Hosomichi, PhD14*, Yoshitaka Zaimoku, MD, PhD15, Fumiaki Kiyomi, PhD16*, Itaru Matsumura, MD17, Koichi Akashi, MD, PhD18* and Shinji Nakao, MD, PhD15,19

1Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan
2Department of Hematology, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan
3Division of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Japan
4Dokkyo Univ. School of Med., Tochigi, JPN
5Kanazawa University Graduate School of Medical Science, Kanazawa-Shi, JPN
6Department of Hematology, Tohoku University Hospital, Sendai, Japan
7NTT Medical Center Tokyo, Tokyo, Japan
8Department of Preventive Medicine and Environmental Health, Osaka Metropolitan University Graduate School of Medicine, Osaka, JPN
9Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan
10Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Toon, Japan
11Kyoto University, Sakyoku, KYO, Japan
12Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences,, Doshisha Women’s College of Liberal Arts, Kyotanabe, Japan
13Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA
14Laboratory of Computational Genomics, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan
15Department of Hematology, Kanazawa University, Kanazawa, Japan
16Clinical Research Support Center Kyushu, Clinical Research Support Center Kyushu, Fukuoka, Japan
17Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan
18Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
19Japanese Red Cross Ishikawa Blood Center, Kanazawa, Japan

Carmelo Gurnari, MD, PhD1,2, Elisa Galossi1*, Eleonora Lumia1*, Alfonso Piciocchi3*, Mariadomenica Divona1*, Tiziana Ottone1*, Elisa Casciani1*, Francesca Romano1*, Elisa Diral, MD4*, Alessandro Tomelleri, MD5*, Federico Caroni6*, Antonio Vitale7*, Gregorio Maria Bergonzi, MD4*, Annalisa Condorelli8*, Giorgia Battipaglia, MD9*, Erika Morsia10*, Antonella Poloni, PhD11*, Elena Crisa, MD12*, Daniela Caravelli12*, Paola Triggianese1*, Arianna Savi, MD13*, Chiara Cardamone, MD14*, Matteo Dragani, MD15*, Giulia Rivoli, MD15*, Federica Pilo, MD16*, Davide Firinu17*, Sara Plebani18*, Francesco D'Agostino19*, Alessandro D'Ambrosio, MD20*, Katja Sockel, MD21*, Antonio Curti, MD, PhD22, Cristina Papayannidis, MD, PhD23, Marco Frigeni8*, Attilio Olivieri10*, Fabrizio Pane24, Monica Bocchia, MD6*, Luca Cantarini7*, Alessandro Rambaldi25, Corrado Campochiaro, MD5*, Lorenzo Dagna, MD26*, Raffaella Greco, MD27*, Fabio Ciceri, MD28*, Orietta Spinelli8*, Christian Thiede, MD21 and Maria Teresa Voso, MD1

1Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
2Cleveland Clinic Foundation, Cleveland, OH
3GIMEMA Foundation, Rome, Italy
4Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy
5Unit of Immunology, Rheumatology, Allergy and Rare diseases, IRCCS San Raffaele Hospital, Milano, Italy
6Hematology, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy
7Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena and Azienda Ospedaliero-Universitaria Senese [European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center, Siena, Italy
8Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
9Federico II University of Naples, Hematology Department, Naples, Italy, Naples, Italy
10Clinica di Ematologia Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy
11Hematology Unit, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy
12Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
13University of Turin, Department of Clinical and Biological Sciences, Turin, Italy
14Division of Allergy and Clinical Immunology, University of Salerno, Salerno, Italy
15Hematology and Cellular Therapy Division, IRCCS Ospedale Policlinico San Martino, Genova, Italy
16Hematology and BMT Unit, A.Businco hospital, AOB Cagliari, Italy, Cagliari, Italy
17Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
18Hematology, San Salvatore Hospital, L'Aquila, Italy
19UOC Hematology, IRCCS Ospedale Casa Sollievo della sofferenza, San Giovanni Rotondo, Italy
20AORN S.Anna e S. Sebastiano, Caserta, Italy
21University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
22Istituto di Ematologia "Seràgnoli", IRCCS Azienda Ospedaliero–Universitaria di Bologna, Bologna, Italy
23IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
24Division of Hematology and SCT Unit, Federico II University, Naples, Naples, Italy
25Department of Oncology-Hematology, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
26Unit of Immunology, Rheumatology, Allergy and Rare diseases, IRCCS San Raffaele Hospital, Milan, Italy
27Unit of Hematology and Stem Cell Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy
28Hematology and Bone Marrow Transplantation Unit, I.R.C.C.S. San Raffaele Scientific Institute, Milan, Italy

Talya Wittmann Dayagi, MD1,2*, Laura Willis3*, Catherine Corriveau-Bourque, MD4, Michaela Cada, MD, FRCPC, MPH1,2*, Zora R. Rogers, MD5, Taizo A. Nakano, MD6, Timothy S. Olson, MD, PhD7,8, Winfred C. Wang, MD9, Alfred Gillio, MD10, Thomas D. Coates, MD11,12, Anjulika Chawla, MD, FAAP13, Paul Castillo, MD14, Peter Kurre, MD7,8, Christopher Gamper, MD, PhD15, Staci D. Arnold, MD, MBA, MPH16*, Sarita Joshi, MD, MBBS17, Amy E. Geddis, MD, PHD18*, Jessica Boklan, MD, MPH19, Jennifer A. Rothman, MD20, James N. Huang, MD21, Gary M. Kupfer, MD22, Bertil Glader, MD, PhD23,24, Kelly J. Walkovich, MD25, Alexis Thompson, MD, MPH26,27, Rabi Hanna, MD28, David A. Williams, MD29,30, Akiko Shimamura, MD, PhD31 and Yigal Dror, MD, FRCPC1,2,32,33

1Department of Paediatrics, University of Toronto, Toronto, ON, Canada
2Marrow Failure and Myelodysplasia Program, Division of Haematology and Oncology, The Hospital for Sick Children, Toronto, ON, Canada
3Division of Haematology and Oncology, The Hospital for Sick Children, Toronto, Canada
4University of Alberta, Edmonton, AB, CAN
5Children's Medical Center Dallas Ctr. for Cancer & Blood Disorders, Dallas, TX
6Children's Hospital Colorado, Denver, CO
7Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA
8Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
9Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
10Hackensack University Medical Center, Hackensack, NJ
11Pediatrics and Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA
12Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, CA
13bluebird bio, Inc., Somerville, MA
14Pediatric Hematology Oncology Division, UF Health Shands Children's Hospital, Gainesville, FL
15Johns Hopkins University School of Medicine, Baltimore, MD
16Aflac Canver and Blood Disorders Center at Children's Healthcare of Atlanta, Emory University, Atlanta
17Fortea Inc., Burlington, NC
18Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, WA
19Department of Child Health, University of Arizona College of Medicine, Phoenix, AZ
20Duke University Medical Center, Durham, NC
21UCSF Benioff Children's Hospital, San Francisco, CA
22Georgetown University Medical Center, Washington, DC
23Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
24Lucile Packard Children’s Hospital, Palo Alto, CA
25C.S. Mott Children’s Hospital, University of Michigan, Ann Arbor, MI
26Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA
27Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
28Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
29Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA
30Hematology/Oncology, Boston Children's Hospital, Boston, MA
31Boston Children's Hospital, Boston, MA
32Genetics & Genome Biology Program, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada
33Institute of Medical Science, University of Toronto, Toronto, ON, Canada

Caroline Piatek, MD1, Jong Wook Lee2, Morag Griffin, MBChB, MRCP3*, Jun-Ichi Nishimura4, Christopher Patriquin, MD, MSc, FRCPC5, Hubert Schrezenmeier, MD6,7, Wilma Barcellini, MD8*, Jamile Shammo, MD9, Anna Gaya10*, Mohammed Mahdi11*, Peng Liu11*, Karl-Johan Myren11*, Andrew Messali11*, Flore Sicre de Fontbrune, MD12*, Jens Panse, MD13,14 and Austin G. Kulasekararaj, MD, MBBS, FRCPath, MRCP15

1Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, USC Norris Comprehensive Cancer Center, Los Angeles, CA
2Hanyang University Seoul Hospital, Seoul, Korea, Republic of (South)
3Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
4Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
5Division of Medical Oncology & Hematology, University Health Network, Toronto, ON, Canada
6Institute of Transfusion Medicine, University of Ulm, Ulm, Germany
7Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, University Hospital of Ulm and German Red Cross Blood Service Baden-Württemberg-Hessen, Ulm, Germany
8Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
9Feinberg School of Medicine, Northwestern University, Chicago, IL
10Hospital Clínic de Barcelona, Barcelona, Spain
11Alexion, AstraZeneca Rare Disease, Boston, MA
12Centre de Référence Aplasie Médullaire, Service d’Hématologie Greffe, Assistance Publique des Hôpitaux de Paris, Hôpital Saint-Louis, Paris, France
13Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany
14Center for Integrated Oncology, Aachen Bonne Cologne Düsseldorf (ABCD), Aachen, Germany
15King’s College Hospital-NHS Foundation Trust, NIHR/Wellcome King’s Clinical Research Facility, and King’s College London, London, United Kingdom

Jibran Durrani, MD1, Leonard Chen2*, Nuri Cha3*, Zhijie Wu, MD, PhD4*, Shouguo Gao, PhD4*, Hiroki Mizumaki, MD5*, Jennifer Lotter, ms4, Olga Rios4*, Colin O. Wu, PhD6*, Willy Albert Flegel, MD2, Neal S. Young, MD4, Emma M. Groarke, MD4 and Bhavisha A. Patel, MD4

1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, BETHESDA, MD
2NIH, Bethesda, MD
3NIH Clinical Center, National Institutes of Health, Bethesda, MD
4Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
5Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Washington, MD
6Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Hubert Schrezenmeier, MD1,2, Mohammed Mahdi3*, Christoph Gasteyger, MD3* and Cecile De Coster3*

1Institute for Transfusion Medicine, Ulm University, Ulm, Germany
2Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm, Ulm, Germany
3Alexion, AstraZeneca Rare Disease, Boston, MA

Munevver N. Duran, BA1*, Zehra Tombul1*, Mutlu Mete2*, Ahmet Celal Toprak3*, Olisaemeka Ogbue, MBBS4, Hussein Awada5, Carmelo Gurnari, MD, PhD6, Jaroslaw Maciejewski5, Ibrahim F. Ibrahim, MD7, Merve Ozturk1*, Yusuf M. Ozcan8*, Brielle Johnson1*, Christine Ejiofor1*, Alper Olcal1* and Taha Bat7

1UT Southwestern Medical Center, Dallas, TX
2Department of Information Science, University of North Texas, Denton, TX
3University of Texas Southwestern Medical Center, Dallas, TX
4Fairview Hospital, Cleveland Clinic Foundation, Rocky River, OH
5Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
6Cleveland Clinic Foundation, Cleveland, OH
7Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX
8University of Texas Dallas, Richardson, TX

Derek Chan, MD, PhD1,2, Meltem Omur, MS3,4*, Diana Lin, MSc5*, Wyeth Wasserman, PhD3,4*, Aly Karsan, MD, FRCPC5,6 and Suzanne Vercauteren, MD, PhD, FRCPC6,7

1The Hospital for Sick Children, Toronto, ON, Canada
2Division of Haematology/Oncology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada
3Centre for Molecular Medicine and Therapeutics, British Columbia Children’s Hospital Research Institute, Vancouver, BC, Canada
4Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
5Canada’s Michael Smith Genome Sciences Centre, BC Cancer Research Centre, Vancouver, BC, Canada
6Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
7British Columbia Children’s Hospital Research Institute, Vancouver, BC, Canada

Weiwang Li1,2,3*, Lele Zhang1,2,3*, Hong Pan1,2,4*, Zhen Gao1,2,3*, Jianping Li1,2,3*, Neng Nie1,2,3*, Xin Zhao1,2,3, Jinbo Huang2,3,5*, Jingyu Zhao, MSc1,2,3*, Xiao Yu1,2,3*, Zhexiang Kuang1,2,3*, Liwei Fang1,2,3*, Meili Ge1,2,3*, Weiping Yuan1,2 and Jun Shi, MD1,2,3*

1State Key Laboratory of Experimental Hematology,National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2Tianjin Institutes of Health Science, Tianjin, China
3Red Blood Cell Diseases Center & Regenerative Medicine Clinic, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
4Red Blood Cell Diseases Center & Regenerative Medicine Clinic, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, AL, China
5State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China, Tianjin, China

Elias H Atta, MD, PhD1,2, Décio Lerner, MsC3*, Ana Paula Villela, MsC4* and Leonardo Javier Arcuri, MD, PhD3,5*

1CEMO, Instituto Nacional de Câncer, Rio De Janeiro, Brazil
2Oncoclínicas Brasil, Rio de Janeiro, Brazil
3CEMO, Instituto Nacional de Câncer, Rio de Janeiro, Brazil
4Laboratório de Imunogenética, Instituto Nacional de Câncer, Rio de de Janeiro, Brazil
5Hospital Israelita Albert Eistein, São Paulo, Brazil

Fengkui Zhang1*, Li Zhang1*, Chen Yang2*, Changhe Yue3*, Jay Ma4*, Chaomei He4*, Ping Tsui4*, Qing Yu Christina Weng4*, Helen Fu4*, Hui Yan3*, Wenru Song4 and Bing Han2*

1Institute of Hematology & Blood Diseases Hospital, Tianjin, China
2Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China
3Kira Pharmaceuticals (Suzhou) Limited, Suzhou, China
4Kira Pharmaceuticals (US), Cambridge, MA

Michelle Zhu1*, Prajwal Sharma1*, Mutlu Mete2*, Alper Olcal1*, Ibrahim F. Ibrahim, MD3, Weina Chan4* and Taha Bat3

1University of Texas Southwestern Medical Center, Dallas, TX
2Department of Information Science, University of North Texas, Denton, TX
3Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX
4Department of Pathology, University of Texas Southwestern Medical Center, Dallas

Fengkui Zhang1*, Li Zhang1,2*, Miao Chen3*, Hongyan Tong4, Xiaoni Li5*, Wei Wang5*, Li Liu5* and Geoffrey Ross6*

1Institute of Hematology & Blood Diseases Hospital, Tianjin, China
2Tianjin Institutes of Health Science, Tianjin, China
3Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China
4The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
5Wuhan Createrna Science and Technology Co., Ltd, Wuhan, China
6Wuhan Createrna Science and Technology, Ltd, Cornwall, United Kingdom

Yuemin Gong, M.D., PhD1*, Yawen Zhang2*, Jianyong Li, MD3, Guangsheng He4* and Lei Fan5*

1Department of Hematology, Department of Hematology, The First Affiliated Hospital of Nanjing Medical University ,Jiangsu Province Hospital,Nanjing,China, Nanjing, China
2Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
3First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
4The First Affiliated Hospital with Nanjing Medical University, NANJING, China
5Lymphoma Center, Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

*signifies non-member of ASH